Kailera Therapeutics, Inc. Common Stock (KLRA) — Defensive Interval Ratio
Kailera Therapeutics, Inc. Common Stock (KLRA) has a Defensive Interval Ratio of 3458 days as of June 2026. Defensive assets of $792.55 Million (cash $-, short-term investments $786.44 Million, receivables $6.11 Million) cover 3458 days of daily cash needs of $229.18K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Kailera Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Kailera Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 3458 days, meaning defensive assets of $792.55 Million can fund 3458 days of operations without new revenue. For the complete balance sheet picture, see KLRA total asset value.
Annual Defensive Interval Ratio for Kailera Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Kailera Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Kailera Therapeutics, Inc. Common Stock (KLRA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3056 days | $388.51 Million | $127.14K/day | $- | $385.79 Million | ▲ +3056 days |
| 2024 | 0 days | $0.00 | $18.93K/day | $- | $0.00 | — |